Sofimac Innovation. 11 12 2020 the partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes1. Basel 11 december 2020.
And terumo corporation enter into joint development agreement with exclusive distribution right for dblg1 automated insulin delivery solution in japanese market. The french company diabeloop a pioneer in therapeutic ai and terumo corporation a global leader in medical technology announced today that they have signed an agreement for the joint development with. By angelika machine knitter since 1987.
We are present in paris lyon rennes and marseille as close as possible to the major innovation centers in france.
We are present in paris lyon rennes and marseille as close as possible to the major innovation centers in france. Pertinence invest 2 is an investment fund managed by sofimac innovation a french independent venture capital firm. Raised in partnership with prestigious universities and schools pertinence invest 2 is investing in breakthrough technologies in the engineering sciences and health nutrition sectors. Basée à paris lyon rennes et aix en provence elle est issue du.
